NEW YORK--(BUSINESS WIRE)--The Rosen Law Firm, P.A. announces that it is investigating potential securities claims against IRadimed Corporation (NASDAQ:IRMD) resulting from allegations that the Company issued materially false statements to investors.
On September 3, 2014, IRadimed Corporation shocked the market when it announced that it received a warning letter from the FDA stemming from an April 2014 inspection of its facility located in Winter Park, Florida. The warning letter requests that the Company immediately stop all activities that misbrand or adulterate its mRidium 3860 MRI infusion pump, mRidium 3850 MRI infusion pump, and the mRidium 3860+ MRI infusion pump, such as the commercial distribution of the device. This adverse news caused IRadimed Corporation’s stock to fall $3.30 per share, or more than 30% on September 3, 2014.
The Rosen Law Firm is preparing a securities class action lawsuit on behalf of IRadimed Corporation investors. If you would like to recover your losses, please visit the website at http://rosenlegal.com/cases-346.html or for more information concerning the investigation please contact Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at email@example.com or firstname.lastname@example.org.
The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar outcome.